Metraipolis › archive › dc_370de5aebe86

Plasma-Nanomedicine Synergistic Therapy for Brain Diseases: Current Status, Applications, and Challenges — Europe PMC PMID:41750547

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41750547
DOI
10.3390/antiox15020166
License (as archived)
solo-consultazione
Archived
2026-10-07T13:01:37.136Z
SHA-256 of the archived text
6e326d0f8789d2c5de1a477cdad10d0ff3f089ef2260cabb2ad0450f12cfc52d
Stable URL of this page
https://metraipolis.com/documento/dc_370de5aebe86

How to cite

Plasma-Nanomedicine Synergistic Therapy for Brain Diseases: Current Status, Applications, and Challenges — Europe PMC PMID:41750547 — Europe PMC (en), https://europepmc.org/article/MED/41750547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_370de5aebe86 (Metraipolis archive dc_370de5aebe86, sha256 6e326d0f8789d2c5de1a477cdad10d0ff3f089ef2260cabb2ad0450f12cfc52d)
BibTeX
@misc{dc370de5aebe86,
  title = {Plasma-Nanomedicine Synergistic Therapy for Brain Diseases: Current Status, Applications, and Challenges — Europe PMC PMID:41750547},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41750547},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_370de5aebe86; sha256 6e326d0f8789d2c5de1a477cdad10d0ff3f089ef2260cabb2ad0450f12cfc52d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41750547. Agents can read the archived copy with the MCP tool read_document.